<!DOCTYPE html>

<html lang="en" data-theme="light">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Androgens & Erectile Dysfunction Drugs - Essentials of Medical Pharmacology</title>
<link rel="preconnect" href="https://fonts.googleapis.com">
<link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
<link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">

<link rel="stylesheet" href="../styles/main.css">

<script>
MathJax = {
tex: {
inlineMath: [['$', '$'], ['\\(', '\\)']],
displayMath: [['$$', '$$'], ['\\[', '\\]']],
processEscapes: true,
processEnvironments: true
},
svg: { fontCache: 'global' },
options: {
skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
}
};
</script>

<script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>

</head>
<body>
<a href="#main-content" class="skip-link">Skip to main content</a>

<button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
<span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
<span class="theme-toggle-icon dark-icon">üåô</span>
</button>

<div class="reading-progress-container">
<div class="reading-progress-bar" id="reading-progress"></div>
</div>

<!-- Floating TOC -->

<nav class="floating-toc" id="floating-toc">
<div class="floating-toc-header">
<span>üìë</span> Table of Contents
</div>
<ul class="floating-toc-list">
<li><a href="#androgens">Androgens</a></li>
<li><a href="#anabolic-steroids">Anabolic Steroids</a></li>
<li><a href="#antiandrogens">Antiandrogens</a></li>
<li><a href="#5-alpha-reductase">5$\alpha$-Reductase Inhibitors</a></li>
<li><a href="#ed-drugs">Erectile Dysfunction Drugs</a></li>
<li><a href="#pde5-inhibitors">PDE-5 Inhibitors</a></li>
<li><a href="#case-study">Problem Directed Study</a></li>
</ul>
</nav>

<div class="page-wrapper">
<div class="container">
<article class="document-article">
<header class="document-header">
<div class="header-badge">
<span>‚ôÇÔ∏è</span>
<span>Topic 22</span>
</div>
<h1 class="document-title">Androgens and Drugs for Erectile Dysfunction</h1>
<div class="title-meta">
<div class="meta-item">
<span>üìö</span>
<span>Hormones and Related Drugs</span>
</div>
<div class="meta-item">
<span>‚è±Ô∏è</span>
<span>45 min read</span>
</div>
</div>
</header>

<main id="main-content" class="content-wrapper">
            <!-- Section 1: Androgens -->
            <section class="content-section" id="androgens">
                <div class="section-header">
                    <div class="section-number">01</div>
                    <h2 class="section-title">
                        <span class="title-icon">üß¨</span>
                        Androgens (Testosterone)
                    </h2>
                </div>

                <div class="content-card">
                    <p><strong>Testosterone</strong> is the principal male sex hormone produced by the interstitial (Leydig) cells of the testes (5-12 mg/day) under the influence of LH. In many target tissues (prostate, skin), it is converted to the more potent <strong>Dihydrotestosterone (DHT)</strong> by the enzyme $5\alpha$-reductase.</p>

                    <h3>Actions</h3>
                    <ul class="enhanced-list">
                        <li class="list-item"><strong>Sex Organs:</strong> Growth of penis, scrotum, seminal vesicles, prostate.</li>
                        <li class="list-item"><strong>Secondary Sex Characters:</strong> Male pattern hair growth (beard, pubic), thickening of skin, deepening of voice, libido.</li>
                        <li class="list-item"><strong>Anabolic:</strong> Increases muscle mass, bone growth (and epiphyseal fusion), nitrogen retention.</li>
                        <li class="list-item"><strong>Haematological:</strong> Stimulates erythropoiesis.</li>
                    </ul>

                    <h3>Preparations</h3>
                    <p>Testosterone undergoes high first-pass metabolism and is inactive orally.</p>
                    <div class="table-responsive">
                        <table class="comparison-table">
                            <thead>
                                <tr>
                                    <th>Type</th>
                                    <th>Drugs</th>
                                    <th>Route/Duration</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td><strong>Esters (Parenteral)</strong></td>
                                    <td>Testosterone propionate</td>
                                    <td>i.m. short acting (1-2 days)</td>
                                </tr>
                                <tr>
                                    <td></td>
                                    <td>Testosterone enanthate/cypionate</td>
                                    <td>i.m. long acting (2-3 weeks)</td>
                                </tr>
                                <tr>
                                    <td><strong>Alkylated (Oral)</strong></td>
                                    <td>Methyltestosterone, Fluoxymesterone</td>
                                    <td>Oral (Hepatotoxic)</td>
                                </tr>
                                <tr>
                                    <td><strong>Others</strong></td>
                                    <td>Testosterone undecanoate</td>
                                    <td>Oral (Absorbed via lymphatics)</td>
                                </tr>
                                <tr>
                                    <td><strong>Transdermal</strong></td>
                                    <td>Testosterone Gel/Patch</td>
                                    <td>Skin application</td>
                                </tr>
                            </tbody>
                        </table>
                    </div>

                    <div class="callout callout--danger">
                        <div class="callout-header">
                            <span class="callout-icon">‚ò£Ô∏è</span>
                            <h4 class="callout-title">Adverse Effects</h4>
                        </div>
                        <div class="callout-content">
                            <ul>
                                <li><strong>Virilization:</strong> In women (hirsutism, voice change, amenorrhoea) and children.</li>
                                <li><strong>Hepatic:</strong> Cholestatic jaundice (17-alkylated compounds), hepatic carcinoma.</li>
                                <li><strong>Prostate:</strong> Progression of prostate cancer (Contraindicated).</li>
                                <li><strong>Others:</strong> Acne, edema, salt retention, precocious puberty, oligozoospermia (suppression of Gn), lowered HDL.</li>
                            </ul>
                        </div>
                    </div>
                </div>
            </section>

            <!-- Section 2: Anabolic Steroids -->
            <section class="content-section" id="anabolic-steroids">
                <div class="section-header">
                    <div class="section-number">02</div>
                    <h2 class="section-title">
                        <span class="title-icon">üí™</span>
                        Anabolic Steroids
                    </h2>
                </div>

                <div class="content-card">
                    <p>Synthetic androgens with higher anabolic:androgenic activity ratio. However, pure separation of effects is not possible.</p>
                    <p><strong>Drugs:</strong> Methandienone, Nandrolone (Deca-Durabolin), Stanozolol, Oxymetholone.</p>
                    
                    <h3>Uses</h3>
                    <ul class="enhanced-list">
                        <li class="list-item"><strong>Catabolic States:</strong> Acute illness, trauma, surgery (short term benefit).</li>
                        <li class="list-item"><strong>Osteoporosis:</strong> In elderly males (Bisphosphonates are preferred).</li>
                        <li class="list-item"><strong>Anaemia:</strong> Hypoplastic/haemolytic (stimulates erythropoietin).</li>
                        <li class="list-item"><strong>Athletic Performance:</strong> Abuse is common ("Doping"). Increases muscle strength but illegal and carries health risks.</li>
                    </ul>
                </div>
            </section>

            <!-- Section 3: Antiandrogens -->
            <section class="content-section" id="antiandrogens">
                <div class="section-header">
                    <div class="section-number">03</div>
                    <h2 class="section-title">
                        <span class="title-icon">üö´</span>
                        Antiandrogens
                    </h2>
                </div>

                <div class="content-card">
                    <h3>Receptor Antagonists</h3>
                    <p>Block androgen receptors. Used mainly in prostate cancer.</p>
                    <ul class="enhanced-list">
                        <li class="list-item"><strong>Flutamide:</strong> Nonsteroidal. Increases LH secretion (needs to be combined with GnRH agonist). Hepatotoxic.</li>
                        <li class="list-item"><strong>Bicalutamide:</strong> More potent, longer acting, better tolerated. Used in metastatic prostate carcinoma.</li>
                        <li class="list-item"><strong>Cyproterone acetate:</strong> Steroidal (progestational). Inhibits LH release also. Used for precocious puberty, female hirsutism/acne.</li>
                    </ul>
                </div>
            </section>

            <!-- Section 4: 5-alpha Reductase Inhibitors -->
            <section class="content-section" id="5-alpha-reductase">
                <div class="section-header">
                    <div class="section-number">04</div>
                    <h2 class="section-title">
                        <span class="title-icon">üìâ</span>
                        5$\alpha$-Reductase Inhibitors
                    </h2>
                </div>

                <div class="content-card">
                    <p><strong>Finasteride</strong> and <strong>Dutasteride</strong>.</p>
                    <p><strong>Mechanism:</strong> Inhibit the enzyme $5\alpha$-reductase which converts testosterone to DHT. Since DHT is the active hormone in prostate and hair follicles, its deficiency causes prostate atrophy and hair regrowth.</p>
                    
                    <h3>Uses</h3>
                    <ul class="enhanced-list">
                        <li class="list-item"><strong>Benign Prostatic Hypertrophy (BPH):</strong> Reduces prostate size, improves flow. Effect takes months.</li>
                        <li class="list-item"><strong>Male Pattern Baldness:</strong> Finasteride (1 mg) prevents hair loss.</li>
                    </ul>
                    <p><strong>Side Effects:</strong> Decreased libido, impotence, decreased ejaculate volume.</p>
                </div>
            </section>

            <!-- Section 5: ED Drugs -->
            <section class="content-section" id="ed-drugs">
                <div class="section-header">
                    <div class="section-number">05</div>
                    <h2 class="section-title">
                        <span class="title-icon">üíä</span>
                        Drugs for Erectile Dysfunction
                    </h2>
                </div>

                <div class="content-card">
                    <p>Erectile dysfunction (ED) is treated primarily by enhancing the Nitric Oxide (NO) - cGMP pathway.</p>
                </div>
            </section>

            <!-- Section 6: PDE-5 Inhibitors -->
            <section class="content-section" id="pde5-inhibitors">
                <div class="section-header">
                    <div class="section-number">06</div>
                    <h2 class="section-title">
                        <span class="title-icon">üõë</span>
                        Phosphodiesterase-5 (PDE-5) Inhibitors
                    </h2>
                </div>

                <div class="content-card">
                    <p><strong>Sildenafil (Viagra), Tadalafil, Vardenafil.</strong></p>
                    <p><strong>Mechanism:</strong> Selectively inhibit PDE-5 enzyme in the corpus cavernosum $\rightarrow$ prevent breakdown of cGMP $\rightarrow$ sustain NO-mediated smooth muscle relaxation $\rightarrow$ penile erection.</p>
                    <div class="callout callout--info">
                        <div class="callout-header">
                            <span class="callout-icon">üí°</span>
                            <h4 class="callout-title">Note</h4>
                        </div>
                        <div class="callout-content">
                            <p>They do not cause erection in the absence of sexual arousal (require NANC nerve stimulation to release initial NO).</p>
                        </div>
                    </div>

                    <div class="table-responsive">
                        <table class="comparison-table">
                            <thead>
                                <tr>
                                    <th>Drug</th>
                                    <th>Duration</th>
                                    <th>Onset</th>
                                    <th>Notes</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td><strong>Sildenafil</strong></td>
                                    <td>4-6 hours</td>
                                    <td>30-60 min</td>
                                    <td>Take on empty stomach (food delays absorption). Visual disturbances (Blue vision).</td>
                                </tr>
                                <tr>
                                    <td><strong>Tadalafil</strong></td>
                                    <td>24-36 hours</td>
                                    <td>30-60 min</td>
                                    <td>"Weekend pill". Less visual side effects. May cause back pain.</td>
                                </tr>
                                <tr>
                                    <td><strong>Vardenafil</strong></td>
                                    <td>4-5 hours</td>
                                    <td>30 min</td>
                                    <td>Similar to Sildenafil.</td>
                                </tr>
                            </tbody>
                        </table>
                    </div>

                    <div class="callout callout--danger">
                        <div class="callout-header">
                            <span class="callout-icon">‚ö†Ô∏è</span>
                            <h4 class="callout-title">Contraindication: NITRATES</h4>
                        </div>
                        <div class="callout-content">
                            <p>PDE-5 inhibitors markedly potentiate the hypotensive action of organic nitrates (Nitroglycerine, Isosorbide mononitrate). <strong>Concomitant use is absolutely contraindicated</strong> as it can cause precipitous fall in BP, MI, and death.</p>
                        </div>
                    </div>

                    <h3>Other Drugs</h3>
                    <p><strong>Alprostadil ($PGE_1$):</strong> Injected intracavernosally. Used in patients not responding to PDE-5 inhibitors.</p>
                </div>
            </section>

            <!-- Section 7: Case Study -->
            <section class="content-section" id="case-study">
                <div class="section-header">
                    <div class="section-number">07</div>
                    <h2 class="section-title">
                        <span class="title-icon">ü§î</span>
                        Problem Directed Study
                    </h2>
                </div>

                <div class="content-card">
                    <div class="callout callout--note">
                        <div class="callout-header">
                            <span class="callout-icon">üìù</span>
                            <h4 class="callout-title">Case 21.1</h4>
                        </div>
                        <div class="callout-content">
                            <p>A 65-year-old man with prostate cancer was prescribed Triptorelin (GnRH agonist). After 1 week, he reported increased bone pain and urinary difficulty. PSA levels rose.</p>
                            <p><strong>(a) Cause of Flare:</strong> This is the <strong>"Flare phenomenon"</strong>. GnRH agonists initially stimulate pituitary GnRH receptors causing a surge in LH and Testosterone secretion before downregulation sets in. The initial rise in testosterone stimulated the prostate cancer, worsening symptoms.</p>
                            <p><strong>(b) Prevention:</strong> Yes, it could be avoided by starting an <strong>Antiandrogen</strong> (like Flutamide or Bicalutamide) a few days before and continuing for weeks after starting Triptorelin. This blocks the action of the initial testosterone surge.</p>
                            <p><strong>(c) Relief of Bone Pain:</strong> <strong>Bisphosphonates</strong> (like Zoledronate) or Denosumab can be given to relieve bone pain and prevent skeletal events associated with metastasis.</p>
                        </div>
                    </div>
                </div>
            </section>

        </main>

        <nav class="document-nav">
            <div class="nav-container">
                <a href="topic-21-corticosteroids.html" class="nav-button nav-button--large nav-button--previous">
                    <div class="nav-label">Previous</div>
                    <div class="nav-title">Corticosteroids</div>
                </a>
                
                <div class="document-progress">
                    <div class="progress-indicator">
                        <span>22</span>
                        <span class="progress-separator">/</span>
                        <span>27</span>
                    </div>
                    <div class="progress-bar-container">
                        <div class="progress-bar-fill" style="width: 81%;"></div>
                    </div>
                    <div class="progress-label">Topic Progress</div>
                </div>
                
                <a href="topic-23-estrogens.html" class="nav-button nav-button--large nav-button--next">
                    <div class="nav-label">Next</div>
                    <div class="nav-title">Estrogens & Contraceptives</div>
                </a>
            </div>
        </nav>
    </article>
</div>
</div>

<script src="../js/theme.js"></script>

<script src="../js/navigation.js"></script>

<script src="../js/interactions.js"></script>

</body>
</html>
